Trials / Unknown
UnknownNCT01482585
Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
to determine the values of imaging and genetic biomarkers for prediction of tumor aggressiveness and prognosis in patient with early stage lung adenocarcinoma to Identify unique copy number alteration in patient with early stage lung adenocarcinoma to evaluate the long-term change of ground-glass nodule combined with lung adenocarcinoma to suggest a guideline for planning an appropriate follow-up examination and management
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CT, PET, copy number alteration | Duel-energy CT, PET, copy number alteration |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2016-07-01
- Completion
- 2016-12-01
- First posted
- 2011-11-30
- Last updated
- 2011-11-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01482585. Inclusion in this directory is not an endorsement.